Evolution of the Average Target: Orange

Evolution of the Target Price: Orange

Changes in Analyst Recommendations: Orange

475e2c3fd37.KrlY6_SbZu1Vd4DS89aO8UYrj0-7ZWUKrz8mOqvZ-fg.G-AipMXhM6c-GsiKx7f5xANN5XiKLVZe1mdtYsGJkZxM7Bm8w8sgph5D1Q~c58f0658468e0ac82bb9a3de26a1c7c5
ORANGE : Oddo BHF confirms its recommendation 07-10 CF
ORANGE : A discount that is shrinking 04-24Alphavalue
ORANGE : Deutsche Bank still a buyer, with E15.5 TP 04-14 CF
ORANGE : Oddo BHF raise TP 04-11 CF
AlphaValue/Baader Europe Downgrades Orange to Add, Trims PT 04-01 MT
Citi Downgrades Orange SA to Neutral 03-26 MT
ORANGE : UBS remains positive after annual results 02-14 CF
ORANGE : Oddo BHF raises its price target on the stock 02-14 CF
ORANGE : French flag penalty gone with continued strong performances 02-13Alphavalue
Bernstein shakes up European telecom sector, raises Telenor and lowers Orange 01-23 FW
Bernstein Downgrades Orange to Market Perform, Lowers PT 01-23 MT
Oddo BHF Upgrades Orange to Outperform, Lifts PT 01-15 MT
ORANGE : An opportunity to buy the second-best European telco over 2022-23 12-05Alphavalue
Morgan Stanley Downgrades Orange to Equalweight, Reduces PT 12-04 MT
ORANGE : Solid EBITDAaL growth coupled with continued dividend growth for 2024 24/10/24Alphavalue
Nextgen Research Downgrades Orange to Neutral 03/10/24 MT
ORANGE : Organic cash flow up by more than 15% in the H1 24/07/24Alphavalue
Nextgen Research Upgrades Orange to Outperform from Neutral 09/07/24 MT
ORANGE : Altice is not out of the woods 10/06/24Alphavalue
Oddo BHF Downgrades Orange to Neutral from Outperform, Trims PT 25/04/24 MT
ORANGE : The market appears to assign no value to MASORANGE 24/04/24Alphavalue
ORANGE : A favourable ruling on the Spanish merger is expected to boost the stock 26/10/23Alphavalue
BofA Securities Upgrades Orange to Buy From Underperform 04/10/23 MT
ALTICE : a house of cards touchy to evaluate 15/09/23Alphavalue
UBS Reiterates Orange's Buy Rating, Trims PT 07/09/23 MT
More recommendations

Consensus (Composite) Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Ecart obj. / dr
+8.37%
+16.62%
+15.17%
+23.06%
+27.89%
+15.05%
+12.1%
+9.47%
+16.73%
+7.91%
Average +15.24%
Weighted average by Cap. +16.96%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
12.97EUR
Average target price
14.06EUR
Spread / Average Target
+8.37%
High Price Target
16.20EUR
Spread / Highest target
+24.90%
Low Price Target
8.800EUR
Spread / Lowest Target
-32.15%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue Jean-Michel Salvador
AlphaValue/Baader Europe
Citigroup
Bernstein
ODDO BHF
Morgan Stanley
Nextgen Research
BofA Securities
UBS
DEUTSCHE BANK RESEARCH Roshan Ranjit
BERNSTEIN RESEARCH Stan Noel
Barclays
GOLDMAN SACHS Andrew Lee
CREDIT SUISSE Jakob Bluestone
DEUTSCHE BANK Roshan Ranjit
JPMORGAN Akhil Dattani
Argus
JEFFERIES Jerry Dellis
KEPLER CHEUVREUX
BERENBERG Abhilash Mohapatra
DZ BANK Matthias Volkert
HSBC Nicolas Cote-Colisson
RBC
MACQUARIE Guy Peddy
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings

Quarterly revenue - Rate of surprise